Jim is Chief Executive of Cambridge Enterprise. He has over 25 years of experience across industry and university environments in both Silicon Valley and the Cambridge Massachusetts innovation ecosystem.

Prior to joining Cambridge Enterprise in 2024 Jim was Co-founder and President of two biotech companies, Atalanta Therapeutics and Clade Therapeutics. He also served as Executive Vice Chancellor – Innovation and Business Development at UMASS Medical School. Prior to these role, Jim was a venture capitalist for ~20 years, as General Partner and Life-Science Co-Lead at Palo Alto based firm Technology Partners Venture Capital.

Jim completed a post-doctoral fellowship at University of California, Berkeley and holds a PhD in Biology from Harvard University, a Deutscher Akademischer Austauschdienst Fellowship at Universität des Saarlandes and a BS from Duke University.